According to Stratistics MRC, the Global Radiotherapy market is accounted for $6.87 billion in 2017 and is expected to reach $13.39 billion by 2026 growing at a CAGR of 7.7% during the forecast period. Factors such as increasing number of cancer patients and untapped market in some emerging countries are fuelling the market growth. However factors such as expensive treatments, adequate infrastructure and adequate skills and training are hampering the market growth.

On the basis of Type, External beam radiotherapy is a category of radiotherapy. As it is an advanced radiotherapy technique it lessens the amount of normal tissue being treated in the applied environment. An external source of ionizing radiation is passed through the particular part of the patient who is suffering from tumour. It increases the quality and accuracy of finding target, and changing the amount of healthy tissue in the treatment field. This can be beneficial from some treatment sites where the objective volume is surrounded by a number of organs which must be spared radiation dose.

By Geography, North American region is expected to surpass other regions due to technological advancements, increasing healthcare expenditure, and high adoption of radiotherapy products owing to the increasing incidence of cancer followed by the Asia pacific region.

Some of the key players in the Radiotherapy market are Accuray Incorporated, C. R. Bard, Inc., Siemens, Elekta AB, IBA (Ion Beam Applications Sa), Isoray Medical, Inc., Mevion Medical Systems, Inc., Mitsubishi Electric Corporation, Nordion, Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Pronova Solutions, LLC., Raysearch Laboratories, Theragenics Corporation, Varian Medical Systems, Inc., Viewray Inc., ProTom International,Inc., Covidien Ltd, Eckert & Ziegler BEBIG SA and Provision Healthcare.

Product Covered:

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
  • Systemic Radiotherapy



Types Covered:

  • External Beam Radiotherapy
  • Internal Beam Radiotherapy
  • Systemic Radiotherapy



Applications Covered:

  • External Beam Radiation Therapy
  • Internal Beam Radiotherapy/Brachytherapy



End-Users Covered:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory & Radiotherapy Centers



Regions Covered:

  • North America
  • ·US
  • ·Canada
  • ·Mexico
  • Europe
  • ·Germany
  • ·UK
  • ·Italy
  • ·France
  • ·Spain
  • ·Rest of Europe
  • Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Australia
  • ·New Zealand
  • ·South Korea
  • ·Rest of Asia Pacific
  • South America
  • ·Argentina
  • ·Brazil
  • ·Chile
  • ·Rest of South America
  • Middle East & Africa
  • ·Saudi Arabia
  • ·UAE
  • ·Qatar
  • ·South Africa
  • ·Rest of Middle East & Africa



What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements